At A Glance: This Prescriber in 2011
Self-Reported Primary Specialty
Rank: 207 out of 536
Rank: 199 out of 536
How Does This Prescriber Compare to Peers?
Antipsychotics to Seniors
42% of this provider’s 200 patients 65 and older filled at least one prescription for an antipsychotic, compared to an average of 21%.
Dangerous Drugs to Seniors
Brand Name Drugs
62% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.
$148 was the average price of a prescription from this provider, compared to $149 among peers.
Prescriptions per Patient
9 is the average number of prescriptions (including refills) per patient, compared to an average of 15.
This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.
KEY: How to read this
Hover to see more prescribers
This Prescriber's Drugs
Search for a Drug
5 questions to ask about a new drug »
via Consumer Health Choices
Compare different prescription drugs »
via Consumer Reports
Click to Filter by Category
A narcotic drug. More » Misuse and abuse of narcotics led to some 16,000 overdose deaths in 2010.
This provider is among the top 10 prescribers of
this drug in the country.
This Drug's Rank
Total Prescriptions Filled
|Category||For this Prescriber||
For All Prescribers in
This Specialty in Illinois
Treats dementia (memory los... +
Treats dementia (memory loss and mental changes) that is a sign of Alzheimer's disease. More info »
Treats severe depression an... +
Treats severe depression and generalized anxiety disorder (GAD). This medicine is a selective serotonin reuptake inhibitor (SSRI). More info »
Treats schizophrenia and ce... +
Treats schizophrenia and certain problems caused by bipolar disorder. More info »
Treats schizophrenia, bipol... +
Treats schizophrenia, bipolar disorder, and depression. Also treats irritability associated with autism. More info »
Treats depression. +
Treats depression. More info »
Rivastigmine is used to tre... +
Rivastigmine is used to treat mild to moderate dementia (memory loss) associated with Alzheimer's disease or Parkinson's disease. More info »
Donepezil is used to treat ... +
Donepezil is used to treat dementia (a brain disorder that affects the ability to remember, think clearly, communicate, and perform daily activities and may cause changes in mood and personality) associated with Alzheimer's disease (AD; a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Donepezil is in a class of medications called cholinesterase inhibitors. It improves mental function (such as memory, attention, social interaction, reasoning and language abilities, and ability to perform activities of daily living) by increasing the amount of a certain naturally occurring substance in the brain. Donepezil may improve the ability to think and remember or slow the loss of these abilities in people who have AD. However, donepezil will not cure AD or prevent the loss of mental abilities at some time in the future. More info »
Citalopram is used to treat... +
Galantamine is used to trea... +
Galantamine is used to treat the symptoms of Alzheimer's disease (AD; a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Galantamine is in a class of medications called acetylcholinesterase inhibitors. It works by increasing the amount of a certain natural substance in the brain that is needed for memory and thought. Galantamine may improve the ability to think and remember or slow the loss of these abilities in people who have AD. However, galantamine will not cure AD or prevent the loss of mental abilities at some time in the future. More info »
About This Data
- No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
- This provider's address and specialty information was last updated on June 17, 2010.